Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog engineered for advanced research applications focused on stimulating endogenous growth hormone (GH) production and influencing downstream insulin-like growth factor-1 (IGF-1) pathways. Structurally designed to closely mimic natural GHRH, Tesamorelin allows for targeted activation of pituitary signaling within controlled research models.
Its mechanism enables researchers to investigate how enhanced GH release may impact metabolic regulation, fat metabolism, and endocrine system balance. Unlike non-selective compounds, Tesamorelin is often studied for its ability to produce a more physiologically aligned GH response, making it particularly valuable in research focused on hormonal optimization and body composition-related pathways.
Manufactured in the United States and verified at ≥99% purity through high performance liquid chromatography (HPLC) and mass spectrometry analysis, each multidose vial is produced to strict research-grade standards for identity, purity, and consistency. This ensures reliability across structured research protocols requiring precision and reproducibility.
In controlled research environments, Tesamorelin has been studied for its role in supporting GH and IGF-1 signaling, influencing fat metabolism pathways, contributing to endocrine system regulation, and enhancing models of recovery, metabolic efficiency, and hormonal balance.
Key Research Focus Areas:
Quality & Compliance:
Important Notice:
For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Scroll for More >>
International Product
A synthetic peptide material manufactured for research applications, with controlled production methods and batch-level testing to support quality verification.
Price range: $65.00 through $125.00
